Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.
about
Targeting the Eph System with Peptides and Peptide ConjugatesNoninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityRadioactive Nanomaterials for Multimodality ImagingProstate cancer characterization by optical contrast enhanced photoacoustics.Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cellsTargeting the EphB4 receptor for cancer diagnosis and therapy monitoring.Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micellesDistinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.Targeting Eph receptors with peptides and small molecules: progress and challenges.Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.Therapeutic targeting of EPH receptors and their ligands.Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer.Eph receptors and ephrins: therapeutic opportunities.Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2.Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor.Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.Silica Nanoparticles for Bimodal MRI-Optical Imaging by Grafting Gd3+ and Eu3+/Tb3+ ComplexesEngineering molecular imaging strategies for regenerative medicine
P2860
Q26799461-51E9CEFE-A244-4606-BDC5-F369C4E17718Q26822871-BD63C0E6-A1C6-4669-9A75-41EE14965BDCQ28741459-891261C7-8ADE-4BB8-879B-AF0EA20CBE4BQ28833646-B9ABF7C1-9B6B-45B3-BFE4-E5C47CF52FB7Q30356016-3F836E8D-6D16-4690-9944-E87995C8F872Q30434365-2BBA4A09-CF6B-4E17-B5BA-A77E3FC7607DQ34216877-E2C9D99D-3C88-445A-AC49-3E8E1BF12A14Q35388439-D29386D3-28DA-449C-A7F8-5B82BB026505Q35676082-B71955C3-9D41-4EC1-BC82-11D306C6F196Q36518309-2C9426B5-33A1-4EA7-A3C4-67E77465529CQ36766095-04ADD212-DD5E-48E9-A8B0-5C50E3CED55DQ36914295-3B5138C5-02F5-41BC-92B7-3030402B9D86Q37625705-44A7FBEE-A763-431C-9990-787C86C7C93DQ37951723-2764CC9A-78A5-4D44-A561-376EA2AB5FBEQ38027231-322D9CD9-A2F7-4F04-BA07-13AD7BBBE517Q38174793-52B28B38-FA85-4D48-AD51-CC754787754EQ38247299-F7963972-9574-4ECC-BC4C-5552F45FA0ABQ38256977-A9A4DAD8-9194-43C6-8AA4-217178781EC3Q38257853-98BB4FBA-A1FE-421C-9249-C278494F4D4FQ38952546-3E384141-C51C-42D6-B72D-7A75BC459F99Q39264449-12DB162B-B124-4350-BF36-C1BEA2F3010DQ48351852-D10C72D3-2CA1-4094-B4DC-E39B6F6FD461Q53395692-E1CD214D-F8E3-4FA5-9F67-AC55B2DCB975Q57651288-D68A615B-B63D-49C5-81A3-627E3915270DQ58120574-78AE4234-1234-4358-9CD4-9553BB323827
P2860
Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@ast
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@en
type
label
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@ast
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@en
prefLabel
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@ast
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@en
P2093
P2860
P1433
P1476
Peptide-conjugated polymeric m ...... in prostate cancer xenografts.
@en
P2093
Chiyi Xiong
Dong Liang
Miao Huang
Qian Huang
Xiaoxia Wen
P2860
P304
P356
10.1016/J.BIOMATERIALS.2011.04.070
P577
2011-05-25T00:00:00Z